Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - Radius Health, Inc.rdus09301710qex31d2.htm
EX-31.1 - EXHIBIT 31.1 - Radius Health, Inc.rdus09301710qex31d1.htm
EX-10.4 - EXHIBIT 10.4 - Radius Health, Inc.rdus09301710qex10d4.htm
EX-10.1 - EXHIBIT 10.1 - Radius Health, Inc.rdus09301710qex10d1.htm
10-Q - 10-Q - Radius Health, Inc.rdus0930201710-q.htm


Exhibit 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
Each of Jesper Høiland and Jose Carmona hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as President and Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), respectively, of Radius Health, Inc. (the “Company”), that, to his knowledge, the Quarterly Report of the Company on Form 10-Q for the period ended September 30, 2017 as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date:
November 2, 2017
 
 
 
 
 
 
By:
/s/ Jesper Høiland
 
 
Jesper Høiland

 
 
President and Chief Executive Officer
 
 
 
Date:
November 2, 2017
 
 
 
 
 
 
By:
/s/ Jose Carmona
 
 
Jose Carmona
 
 
Chief Financial Officer
 
This written statement is being furnished to the Securities and Exchange Commission as an exhibit to the Report, and “accompanies” such Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report to which it relates), notwithstanding any general incorporation language contained in such filing. A signed original of this statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.